These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1197 related items for PubMed ID: 10725198

  • 21. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms.
    Aberle JH, Aberle SW, Allison SL, Stiasny K, Ecker M, Mandl CW, Berger R, Heinz FX.
    J Immunol; 1999 Dec 15; 163(12):6756-61. PubMed ID: 10586074
    [Abstract] [Full Text] [Related]

  • 22. Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus.
    Fleeton MN, Chen M, Berglund P, Rhodes G, Parker SE, Murphy M, Atkins GJ, Liljeström P.
    J Infect Dis; 2001 May 01; 183(9):1395-8. PubMed ID: 11294672
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus.
    Bastien N, Trudel M, Simard C.
    Virology; 1997 Jul 21; 234(1):118-22. PubMed ID: 9234952
    [Abstract] [Full Text] [Related]

  • 26. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
    Shafique M, Wilschut J, de Haan A.
    Vaccine; 2012 Jan 11; 30(3):597-606. PubMed ID: 22120195
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus].
    Zeng RH, Gong W, Fang XP, Zhang ZY, Mei XG.
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul 11; 21(4):534-9. PubMed ID: 16176088
    [Abstract] [Full Text] [Related]

  • 29. Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment.
    Plotnicky-Gilquin H, Huss T, Aubry JP, Haeuw JF, Beck A, Bonnefoy JY, Nguyen TN, Power UF.
    Virology; 1999 May 25; 258(1):128-40. PubMed ID: 10329575
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection.
    Kumar M, Behera AK, Lockey RF, Zhang J, Bhullar G, De La Cruz CP, Chen LC, Leong KW, Huang SK, Mohapatra SS.
    Hum Gene Ther; 2002 Aug 10; 13(12):1415-25. PubMed ID: 12215263
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
    Cimica V, Boigard H, Bhatia B, Fallon JT, Alimova A, Gottlieb P, Galarza JM.
    Clin Vaccine Immunol; 2016 Jun 10; 23(6):451-9. PubMed ID: 27030590
    [Abstract] [Full Text] [Related]

  • 35. Chimeric subgroup A respiratory syncytial virus with the glycoproteins substituted by those of subgroup B and RSV without the M2-2 gene are attenuated in African green monkeys.
    Cheng X, Zhou H, Tang RS, Munoz MG, Jin H.
    Virology; 2001 Apr 25; 283(1):59-68. PubMed ID: 11312662
    [Abstract] [Full Text] [Related]

  • 36. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
    Spender LC, Hussell T, Openshaw PJ.
    J Gen Virol; 1998 Jul 25; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
    [Abstract] [Full Text] [Related]

  • 37. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation.
    Barends M, Van Oosten M, De Rond CG, Dormans JA, Osterhaus AD, Neijens HJ, Kimman TG.
    J Infect Dis; 2004 May 15; 189(10):1866-72. PubMed ID: 15122523
    [Abstract] [Full Text] [Related]

  • 38. Effect of preexposure to ultrafine carbon black on respiratory syncytial virus infection in mice.
    Lambert AL, Trasti FS, Mangum JB, Everitt JI.
    Toxicol Sci; 2003 Apr 15; 72(2):331-8. PubMed ID: 12660365
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles.
    Garlapati S, Garg R, Brownlie R, Latimer L, Simko E, Hancock RE, Babiuk LA, Gerdts V, Potter A, van Drunen Littel-van den Hurk S.
    Vaccine; 2012 Jul 27; 30(35):5206-14. PubMed ID: 22713718
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.